Uracin 10% Cream
FDA Label NDC 59088-256

16 label sections · Submitted to the FDA by Puretek Corporation · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Puretek Corporation for the product Uracin 10% (NDC 59088-256). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding description, clinical pharmacology, pharmacokinetics, indications and usage, contraindications, warnings, general, information for patients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Carcinogenesis, Mutagenesis And Impairment Of Fertility:

Long-term animal studies for carcinogenic potential have not been performed on this product to date. Studies on reproduction and fertility also have not been performed.

* Please review the disclaimer below.